Evidence map›Paper›PMID 34253212›Full record

ArticleBMC health services research2021

Patients perspectives on drug shortages in six European hospital settings - a cross sectional study.

Darija Kuruc Poje, Domagoj Kifer, Isabelle Huys, Joao Miranda, Helena Jenzer, Nenad Miljković, Torsten Hoppe-Tichy, Marcin Bochniarz, Roberto Frontini, David G Schwartz and 12 more

Open access · goldAbstract read
In one paragraph

Article in BMC health services research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Impact of drug shortages on the work of hospital pharmacists in Japan.Journal of pharmaceutical policy and practice · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 14 institutions in 10 countries.

Darija Kuruc PojePharmacy Department, General hospital "dr. Tomislav Bardek", Koprivnica, Croatia. darija_kuruc@yahoo.com.ORCID http://orcid.org/0000-0002-7893-786X
Domagoj KiferDepartment of Biophysics, Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia.
Isabelle HuysDepartment of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
Joao MirandaDepartamento de Tecnologias, Escola Superior de Tecnologia e Gestão, Instituto Politécnico de Portalegre, Portalegre, Portugal.
Helena JenzerBerner Fachhochschule Health Professions Ernährung und Diätetik, Zürich, Switzerland.
Nenad MiljkovićPharmacy Department, Institute of Orthopaedic Surgery "Banjica", Belgrade, Serbia.
Torsten Hoppe-TichyPharmacy Department, Heidelberg University Hospital, Heidelberg, Germany.
Marcin BochniarzSpecialist Hospital Brzozów, Podkarpackie Oncological Center, Brzozów, Poland.
Roberto FrontiniEuropean Association of Hospital Pharmacists (EAHP), Brussels, Belgium.
David G SchwartzSchool of Business, Bar-Ilan University, Ramat Gan, Israel.
Vesna Vujić-AleksićFaculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina.
Lana NežićFaculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina.
Eleni RinakiHospital pharmacy, Chania General Hospital "Saint George", Crete, Chania, Greece.
Leonidas TzimisHospital pharmacy, Chania General Hospital "Saint George", Crete, Chania, Greece.
Kim GreenPharmacy Department, Heidelberg University Hospital, Heidelberg, Germany.
Jelena JovanićFaculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina.
Bojana CarićFaculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina.
Danijela MandićFaculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and Herzegovina.
Katarina VilićPharmacy Department, General hospital "dr. Tomislav Bardek", Koprivnica, Croatia.
Tomasz BochenekDepartment of Drug Management, Faculty of Health Sciences, Jagiellonian University Medical College, Kraków, Poland.
Vesna Bačić VrcaPharmacy Department, Clinical hospital Dubrava, Zagreb, Croatia.
Srećko MarušićEndocrinology Department, Clinical hospital Dubrava, Zagreb, Croatia.
University of Banja Luka · BAChania General Hospital ”St. George” · GRHeidelberg University · DEUniversity Hospital Dubrava · HRZabok General Hospital · HRBar-Ilan University · ILBern University of Applied Sciences · CHEuropean Federation of Pharmaceutical Industries and Associations · BEInstitute of Orthopedics Banjica · RSJagiellonian University · PLKU Leuven · BELublin Oncology Center · PLUniversity of Lisbon · PTUniversity of Zagreb · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt is known that drug shortages represent a major challenge for all stakeholders involved in the process, but there is little evidence regarding insights into patients' awareness and perspectives. This study aimed to investigate the patients-perceived drug shortages experience and their view on outcomes in different European hospital settings. Furthermore, we wanted to explore information preferences on drug shortages.

methodsA retrospective, cross sectional, a mixed method study was conducted in six European hospital settings. One hospital (H) from each of this country agreed to participate: Bosnia and Herzegovina (H-BiH), Croatia (H-CR), Germany (H-GE), Greece (H-GR), Serbia (H-SE) and Poland (H-PO). Recruitment and data collection was conducted over 27 months from November 2017 until January 2020. Overall, we surveyed 607 patients which completed paper-based questionnaire. Questions related to: general information (demographic data), basic knowledge on drug shortages, drug shortages experienced during hospitalization and information preferences on drug shortage. Differences between hospital settings were analyzed using Chi-squared test or Fisher's exact test. For more complex contingency tables, Monte Carlo simulations (N = 2000) were applied for Fisher's test. Post-hoc hospital-wise analyses were performed using Fisher's exact tests. False discovery rate was controlled using the Bonferroni method. Analyses were performed using R: a language and environment for statistical computing (v 3.6.3).

results6 % of patients reported experiences with drug shortages while hospitalized which led to a deterioration of their health. The majority of affected patients were hospitalized at hematology and/or oncology wards in H-BiH, H-PO and H-GE. H-BiH had the highest number of affected patients (18.1 %, N = 19/105, p < 0.001) while the fewest patients were in H-SE (1 %, N = 1/100, p = 0.001). In addition, 82.5 %, (N = 501/607) of respondents wanted to be informed of alternative treatment options if there was a drug shortage without a generic substitute available. Majority of these patients (66.4 %, N = 386/501) prefer to be informed by a healthcare professional.

conclusionsAlthough drug shortages led to serious medical consequences, our findings show that most of the patients did not perceive shortages as a problem. One possible interpretation is that good hospital management practices by healthcare professionals helped to mitigate the perceived impact of shortages. Our study highlights the importance of a good communication especially between patients and healthcare professionals in whom our patients have the greatest trust.

Indexed as

Drugs, GenericHospitalsCross-Sectional StudiesGermanyGreeceHumansPolandRetrospective StudiesDrugs, GenericDrug shortagesEuropeHospital settingPatient safetyPatients’ perspectives

Identifiers

PMID34253212
PMCPMC8274960
OpenAlexW3179893541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.